Basic mechanisms of diabetic heart disease

RH Ritchie, ED Abel - Circulation research, 2020 - Am Heart Assoc
Diabetes mellitus predisposes affected individuals to a significant spectrum of
cardiovascular complications, one of the most debilitating in terms of prognosis is heart …

HDAC inhibition reverses preexisting diastolic dysfunction and blocks covert extracellular matrix remodeling

JG Travers, SA Wennersten, B Peña, RA Bagchi… - Circulation, 2021 - Am Heart Assoc
Background: Diastolic dysfunction (DD) is associated with the development of heart failure
and contributes to the pathogenesis of other cardiac maladies, including atrial fibrillation …

Implications of MCU complex in metabolic diseases

C Li, J Sun, X Zhang, M Zhou, X Gan - The FASEB Journal, 2023 - Wiley Online Library
Metabolic diseases are considered the primary culprit for physical and mental health of
individuals. Although the diagnosis of these diseases is relatively easy, more effective and …

Sirt1 and Sirt3 activation improved cardiac function of diabetic rats via modulation of mitochondrial function

B Paramesha, MS Anwar, H Meghwani, SK Maulik… - Antioxidants, 2021 - mdpi.com
In the present study, we aimed to evaluate the effect of Sirt1, Sirt3 and combined activation
in high fructose diet-induced insulin resistance rat heart and assessed the cardiac function …

Dapagliflozin suppresses ER stress and improves subclinical myocardial function in diabetes: from bedside to bench

JY Shih, YW Lin, S Fisch, JT Cheng, NW Kang… - Diabetes, 2021 - Am Diabetes Assoc
Dapagliflozin (DAPA), a sodium–glucose cotransporter 2 inhibitor, is approved for
treatments of patients with diabetes. The DAPA-HF (Dapagliflozin and Prevention of Adverse …

Self-reported satisfaction to treatment, quality of life and general health of type 2 diabetes patients with inadequate glycemic control from north-eastern Romania

ED Grigorescu, CM Lăcătușu, I Crețu… - International Journal of …, 2021 - mdpi.com
Type 2 diabetes mellitus (T2DM) undermines health and quality of life (QoL). This cross-
sectional study surveyed 138 consenting T2DM patients from North-Eastern Romania with …

Assessment of subclinical LV myocardial dysfunction in T2DM patients with diabetic peripheral neuropathy: a cardiovascular magnetic resonance study

XM Li, K Shi, L Jiang, J Wang, WF Yan, Y Gao… - Cardiovascular …, 2024 - Springer
Background Diabetic peripheral neuropathy (DPN) is the most prevalent complication of
diabetes, and has been demonstrated to be independently associated with cardiovascular …

Quercetin alleviates diastolic dysfunction and suppresses adverse pro-hypertrophic signaling in diabetic rats

L Bartosova, C Horvath, P Galis… - Frontiers in …, 2022 - frontiersin.org
Introduction Quercetin (Que) is a potent anti-inflammatory and antioxidant flavonoid with
cardioprotective potential. However, very little is known about the signaling pathways and …

99mTc-HFAPi imaging identifies early myocardial fibrosis in the hypertensive heart

B Xie, L Li, M Lin, M Nanna, Y Su, C Hua… - Journal of …, 2023 - journals.lww.com
Background: This study aimed to explore whether 99m Tc-radiolabeled fibroblast activation
protein inhibitor (99m Tc-HFAPi) imaging can detect early myocardial fibrosis in the …

Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis

BG Han, JY Lee, MR Kim, H Shin, JS Kim, JW Yang… - Plos one, 2020 - journals.plos.org
Background Fluid overload is common in patients with diabetes and chronic kidney disease
(DM and CKD; DMCKD) and can lead to structural and functional cardiac abnormalities …